Repurposing FDA-approved sulphonamide carbonic anhydrase inhibitors for treatment of Neisseria gonorrhoeae
Journal of enzyme inhibition and medicinal chemistry, 2022-12, Vol.37 (1), p.51-61 [Peer Reviewed Journal]2021 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. 2021 ;2021 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. This work is licensed under the Creative Commons Attribution License http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2021 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. 2021 The Author(s) ;ISSN: 1475-6366 ;EISSN: 1475-6374 ;DOI: 10.1080/14756366.2021.1991336 ;PMID: 34894972
Full text available